Safety Considerations for GLP-1 Medications Understanding safety information is essential regardless of which pathway you consider
The higher lows against a flat-top are attempting to break out as the surge initially peaked at $141.87
Healthcare providers and patients can report suspected adverse events to the FDA through the MedWatch program
For cash-pay patients, PlushCare now has more relevance than it did earlier in 2026 because its doctors can prescribe into newer direct-pay pathways: Wegovy cash-pay pathway: from $199/month intro pricing for the first two months at lower doses through NovoCare, then $399/month for maintenance
Lilly plans on discussing the data with regulators, but no plans to seek approval have been announced, according to a spokesperson
You may already be aware that GLP-1-type drugs, including Mounjaro, work only when taken while also implementing lifestyle changes (like working on your sleep, exercise, and eating habits)